Report copyright - 2018 ANNUAL TREND REPORT · 2020-04-30 · FOCUS ON DIABETES As predicted in our 2016 Trend Report, GLP-1 agonist and SGLT2 inhibitors have gained more market share than DPP-IV inhibitors
Please pass captcha verification before submit form